Spoken approach
say this aloud Free preview- This patient has severe secondary hyperparathyroidism, a common complication of CKD-MBD, which is refractory to initial management with phosphate binders and vitamin D analogs.
- My immediate priority is to lower the markedly elevated PTH level to mitigate its systemic effects, including renal osteodystrophy and cardiovascular risk.
- First, I'll confirm the baseline labs, ensuring the corrected serum calcium is at least 8.4 mg/dL. If it is lower, I cannot start cinacalcet and must correct the hypocalcemia first.
+ 8 more steps of the spoken answer for subscribers